SHIRE PHARMACEUTICALS LLC for SHIRE PHARMACEUTICALS LLC
What was lobbied
One issue area, each in the filer's own words, with who lobbied on it and where.
Pharmacy PHA
orphan drug tax credit; issues surrounding ADHD, including economic and social impact; binge eating disorder; drug shortages; DEA processes; FDA funding and sequester; specialty tiers; track and trace; bundling rules for the Hospital Outpatient Prospective Payment System; compassionate use; step therapy; line extension rebates; drug development; patent issues; CMS coding coverage; Medicare Part D rebates; tax reform; R&D tax credits; Priority Review Vouchers; FDASIA implementation
| Lobbyist | Covered position, as disclosed |
|---|---|
| EDWARD BUCKLEY | — |
| JOHN EDWARD GREISSING | — |
| MARK LENKER | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.